Health care; creating the Wrongful Life Act; prohibiting certain services on a minor; authorizing certain civil actions and damages. Effective date.
SB1049 would create the “Wrongful Life Act” and prohibit physicians and other health care professionals from prescribing or performing gender transition surgery, hormone therapy, or puberty-blocking drugs on individuals under 18, except when puberty-blocking drugs are medically necessary. The bill also bars parents or legal guardians from consenting to those treatments on behalf of minors.
The bill creates new civil causes of action for a person who received the prohibited treatment as a minor and later claims the treatment caused loss of “natural reproductivity functions” related to childbearing and rearing. It allows suits against both the health care professional and, in some cases, the parent or guardian who consented, with no time limit for filing except where a rebuttable presumption about fertility is successfully challenged. Available remedies include compensatory damages, punitive damages, other appropriate relief, and recovery of court costs and attorney fees. The bill also adds a criminal penalty, stating that a parent or guardian found to have violated the consent prohibition in cases with potentially grave long-term effects on the child may be guilty of child abuse under existing law.
In state-law terms, SB1049 would add new sections to Title 63 of the Oklahoma Statutes and expressly state that its remedies are in addition to, and do not replace, existing provisions in Section 2607.1. It would significantly expand liability exposure for medical providers and families in connection with gender-affirming care for minors, while also creating a new statutory framework for damages and enforcement. The bill is set to take effect November 1, 2025, if enacted.
There is no recorded committee debate or vote history in the provided materials, so sentiment cannot be measured from official discussion. Based on the bill text alone, the measure appears strongly opposed to gender-affirming care for minors and is framed as a protective and punitive measure. The absence of transcripts or votes means there is no documented bipartisan support or opposition in the supplied record, but the bill’s subject matter suggests it would likely be highly contentious.
The main points of contention are the ban on gender-affirming medical care for minors, the restriction on parental consent, the creation of private lawsuits against both clinicians and parents, and the child-abuse penalty for consenting adults. The bill’s use of fertility-related harm and its rebuttable presumption about a minor’s future ability to bear children may also draw legal and medical criticism, especially regarding causation, medical necessity, parental rights, and the scope of civil and criminal liability.
SB1049 would amend Oklahoma law by creating new provisions in Title 63 that prohibit gender transition surgery, hormone therapy, and puberty-blocking drugs for minors, with a narrow exception for medically necessary puberty blockers. It would also create new civil causes of action against health care professionals and, in some cases, parents or guardians, and it would add a potential child-abuse consequence under Title 21 for certain parental consent violations. The bill would expand remedies, damages, attorney-fee recovery, and filing timelines beyond typical limitations periods, while expressly preserving existing law in Section 2607.1.
No committee transcript or vote data is provided, so there is no documented legislative sentiment from debate or roll call. The bill’s text reflects a clear policy position against gender-affirming care for minors and in favor of enforcement through civil liability and criminal penalties, indicating a strongly supportive posture from the sponsor and likely strong opposition from affected medical, LGBTQ+, and parental-rights stakeholders.
The most significant disputes are likely to center on the prohibition of gender-affirming care for minors, the exclusion of gender transition as a medical necessity, and the ability of minors or adults to sue clinicians and parents for alleged loss of fertility-related functions. Additional controversy is likely over the bill’s no-limit filing period, rebuttable presumption regarding fertility, punitive damages, and the child-abuse provision for parents or guardians who consent. Critics would likely argue the bill intrudes on medical judgment and parental decision-making, while supporters would likely frame it as protecting minors from irreversible treatment.